EA200401398A1 - Замещённые фенилацетамиды и их применение в качестве активаторов глюкокиназы - Google Patents

Замещённые фенилацетамиды и их применение в качестве активаторов глюкокиназы

Info

Publication number
EA200401398A1
EA200401398A1 EA200401398A EA200401398A EA200401398A1 EA 200401398 A1 EA200401398 A1 EA 200401398A1 EA 200401398 A EA200401398 A EA 200401398A EA 200401398 A EA200401398 A EA 200401398A EA 200401398 A1 EA200401398 A1 EA 200401398A1
Authority
EA
Eurasian Patent Office
Prior art keywords
activators
application
glukokinase
group
substituted phenylacetamides
Prior art date
Application number
EA200401398A
Other languages
English (en)
Other versions
EA011297B1 (ru
Inventor
Уэнди Ли Корбетт
Джозеф Самьюэл Гримсби
Нэнси-Эллен Хейнс
Роберт Франсис Кестер
Пейж Эрин Мэхэней
Ягдиш Кумар Рача
Рамакант Сарабу
Ка Ван
Original Assignee
Ф. Хоффманн-Ля Рош Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ф. Хоффманн-Ля Рош Аг filed Critical Ф. Хоффманн-Ля Рош Аг
Publication of EA200401398A1 publication Critical patent/EA200401398A1/ru
Publication of EA011297B1 publication Critical patent/EA011297B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/46—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylureas
    • C07C275/48—Y being a hydrogen or a carbon atom
    • C07C275/50—Y being a hydrogen or an acyclic carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/20—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/10—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/16—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Abstract

В заявке описаны соединения формулы I, где формула II означает замещенную группу, оксациклоалкильную группу или тиациклоалкильную группу. Соединения являются активаторами глюкокиназы и используются для лечения диабета типа II.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200401398A 2002-04-26 2003-04-14 Замещённые фенилацетамиды и их применение в качестве активаторов глюкокиназы EA011297B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US37616102P 2002-04-26 2002-04-26
PCT/EP2003/003844 WO2003095438A1 (en) 2002-04-26 2003-04-14 Substituted phenylacetamides and their use as glucokinase activators

Publications (2)

Publication Number Publication Date
EA200401398A1 true EA200401398A1 (ru) 2005-06-30
EA011297B1 EA011297B1 (ru) 2009-02-27

Family

ID=29420328

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200401398A EA011297B1 (ru) 2002-04-26 2003-04-14 Замещённые фенилацетамиды и их применение в качестве активаторов глюкокиназы

Country Status (35)

Country Link
US (2) US7105671B2 (ru)
EP (1) EP1501815B1 (ru)
JP (1) JP4091600B2 (ru)
KR (1) KR100669587B1 (ru)
CN (1) CN1329386C (ru)
AR (1) AR039665A1 (ru)
AT (1) ATE346056T1 (ru)
AU (1) AU2003232204B8 (ru)
BR (1) BR0309546A (ru)
CA (1) CA2482346C (ru)
DE (1) DE60309856T2 (ru)
DK (1) DK1501815T3 (ru)
EA (1) EA011297B1 (ru)
EC (1) ECSP045382A (ru)
ES (1) ES2276097T3 (ru)
GT (1) GT200300096A (ru)
HK (1) HK1078088A1 (ru)
HR (1) HRP20040953A2 (ru)
IL (1) IL164780A (ru)
MA (1) MA27113A1 (ru)
MX (1) MXPA04010605A (ru)
MY (1) MY135222A (ru)
NO (1) NO20044534L (ru)
NZ (1) NZ535706A (ru)
PA (1) PA8572301A1 (ru)
PE (1) PE20040451A1 (ru)
PL (1) PL373701A1 (ru)
PT (1) PT1501815E (ru)
RS (1) RS93604A (ru)
TN (1) TNSN04211A1 (ru)
TW (1) TWI281917B (ru)
UA (1) UA80427C2 (ru)
UY (1) UY27787A1 (ru)
WO (1) WO2003095438A1 (ru)
ZA (1) ZA200407986B (ru)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04115996U (ja) * 1991-03-28 1992-10-15 東洋運搬機株式会社 ボートリフタ
SE0102299D0 (sv) 2001-06-26 2001-06-26 Astrazeneca Ab Compounds
SE0102764D0 (sv) 2001-08-17 2001-08-17 Astrazeneca Ab Compounds
BR0314864A (pt) * 2002-10-03 2005-08-02 Novartis Ag Compostos orgânicos
GB0226931D0 (en) 2002-11-19 2002-12-24 Astrazeneca Ab Chemical compounds
PL378117A1 (pl) * 2003-02-11 2006-03-06 Prosidion Limited Tricyklopodstawione związki amidowe
ES2322709T3 (es) 2004-02-18 2009-06-25 Astrazeneca Ab Derivados de benzamida y su uso como agentes activadores de la glucocinasa.
BRPI0509573A (pt) 2004-04-02 2007-09-25 Novartis Ag derivados de sulfonamida-tiazolpiridina como ativadores de glicocinase úteis para o tratamento de diabetes do tipo 2
MXPA06011365A (es) 2004-04-02 2006-12-15 Novartis Ag Derivados de tiazolo-piridina, composiciones farmaceuticas que los contienen, y metodos para el tratamiento de condiciones mediadas por glucoquinasa.
US20080242869A1 (en) * 2004-04-21 2008-10-02 Matthew Fyfe Tri(Cyclo) Substituted Amide Compounds
TW200600086A (en) 2004-06-05 2006-01-01 Astrazeneca Ab Chemical compound
CN101035767A (zh) * 2004-08-12 2007-09-12 普洛希典有限公司 被取代的苯乙酰胺及其作为葡糖激酶激活剂的用途
GB0418046D0 (en) * 2004-08-12 2004-09-15 Prosidion Ltd Eantioselective process
GB0418058D0 (en) * 2004-08-12 2004-09-15 Prosidion Ltd Fluorination process
US7642259B2 (en) 2005-07-09 2010-01-05 Astrazeneca Ab Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
CN101218237B (zh) * 2005-07-11 2012-03-28 田边三菱制药株式会社 肟衍生物及其制备方法
US20090281142A1 (en) 2005-08-31 2009-11-12 Astellas Pharma Inc. Thiazole derivative
JP2007063225A (ja) 2005-09-01 2007-03-15 Takeda Chem Ind Ltd イミダゾピリジン化合物
WO2007039177A2 (en) 2005-09-29 2007-04-12 Sanofi-Aventis Phenyl- and pyridinyl- 1, 2 , 4 - oxadiazolone derivatives, processes for their preparation and their use as pharmaceuticals
GT200600428A (es) 2005-09-30 2007-05-21 Compuestos organicos
GT200600429A (es) 2005-09-30 2007-04-30 Compuestos organicos
CN101296917A (zh) 2005-10-24 2008-10-29 霍夫曼-拉罗奇有限公司 由法沃斯基重排制备环状缩酮化酮及该方法在制备葡糖激酶活化剂70中的应用
US20080293741A1 (en) * 2005-11-03 2008-11-27 Matthew Colin Thor Fyfe Tricyclo Substituted Amides as Glucokinase Modulators
US8034822B2 (en) 2006-03-08 2011-10-11 Takeda San Diego, Inc. Glucokinase activators
WO2007115968A2 (en) * 2006-04-12 2007-10-18 F. Hoffmann-La Roche Ag Process for the preparation of a glucokinase activator
WO2007115967A1 (en) * 2006-04-12 2007-10-18 F. Hoffmann-La Roche Ag Crystalline isopropanol solvate of glucokinase activator
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
EP2049518B1 (en) 2006-05-31 2011-08-31 Takeda San Diego, Inc. Indazole and isoindole derivatives as glucokinase activating agents.
PE20080993A1 (es) 2006-06-27 2008-10-06 Takeda Pharmaceutical Compuestos ciclicos fusionados como moduladores del receptor gpr40
US7888504B2 (en) 2006-07-06 2011-02-15 Bristol-Myers Squibb Company Glucokinase activators and methods of using same
US7910747B2 (en) 2006-07-06 2011-03-22 Bristol-Myers Squibb Company Phosphonate and phosphinate pyrazolylamide glucokinase activators
BRPI0715531A2 (pt) 2006-07-24 2014-06-24 Hoffmann La Roche Composto, composição farmacêutica, método para o tratamento de uma enfermidade e/ou distúrbio metabólico, processo para a preparação de compostos e uso do composto
TW200819457A (en) 2006-08-30 2008-05-01 Actelion Pharmaceuticals Ltd Spiro antibiotic derivatives
TW200825060A (en) 2006-10-26 2008-06-16 Astrazeneca Ab Chemical compounds
US7902248B2 (en) * 2006-12-14 2011-03-08 Hoffmann-La Roche Inc. Oxime glucokinase activators
WO2008079787A2 (en) 2006-12-20 2008-07-03 Takeda San Diego, Inc. Glucokinase activators
WO2008074694A1 (en) * 2006-12-20 2008-06-26 F. Hoffmann-La Roche Ag Crystallization of glucokinase activators
TW200831081A (en) 2006-12-25 2008-08-01 Kyorin Seiyaku Kk Glucokinase activator
WO2008080822A1 (en) * 2006-12-29 2008-07-10 F. Hoffmann-La Roche Ag Epimerization methodologies for recovering stereo isomers in high yield and purity
WO2008080824A1 (en) * 2006-12-29 2008-07-10 F. Hoffmann-La Roche Ag Aromatic sulfonated ketals
US8314247B2 (en) 2007-01-10 2012-11-20 Mitsubishi Tanabe Pharma Corporation Hydrazone derivative
TW200902489A (en) * 2007-03-07 2009-01-16 Kyorin Seiyaku Kk Glucokinase-activating substance
US8173645B2 (en) 2007-03-21 2012-05-08 Takeda San Diego, Inc. Glucokinase activators
WO2009047798A2 (en) * 2007-10-08 2009-04-16 Advinus Therapeutics Private Limited Acetamide derivatives as glucokinase activators, their process and medicinal applications
CN101918363B (zh) 2008-01-18 2012-09-05 安斯泰来制药株式会社 苯乙酰胺衍生物
US8258134B2 (en) * 2008-04-16 2012-09-04 Hoffmann-La Roche Inc. Pyridazinone glucokinase activators
US7741327B2 (en) 2008-04-16 2010-06-22 Hoffmann-La Roche Inc. Pyrrolidinone glucokinase activators
AU2009241137B2 (en) 2008-04-28 2013-10-03 Kyorin Pharmaceutical Co., Ltd. Cyclopentylacrylic acid amide derivative
US20110021570A1 (en) 2009-07-23 2011-01-27 Nancy-Ellen Haynes Pyridone glucokinase activators
US8222416B2 (en) 2009-12-14 2012-07-17 Hoffmann-La Roche Inc. Azaindole glucokinase activators
ES2624780T3 (es) 2010-03-31 2017-07-17 The Scripps Research Institute Reprogramación de células
US8178689B2 (en) 2010-06-17 2012-05-15 Hoffman-La Roche Inc. Tricyclic compounds
EP2878339A1 (en) 2013-12-02 2015-06-03 Siena Biotech S.p.A. SIP3 antagonists
RU2742771C2 (ru) 2016-08-31 2021-02-10 Цзянсу Хэнжуй Медицин Ко., Лтд. Производное оксопиколинамида, способ его получения и его фармацевтическое применение
GB201714777D0 (en) 2017-09-14 2017-11-01 Univ London Queen Mary Agent
US11076596B2 (en) 2017-09-18 2021-08-03 Basf Se Substituted trifluoromethyloxadiazoles for combating phytopathogenic fungi

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE249241C (ru) 1910-05-01 1912-07-13
US3431301A (en) * 1966-03-24 1969-03-04 Hoffmann La Roche Process for producing methylhydrazine derivatives
US3776917A (en) * 1972-06-05 1973-12-04 Schering Corp 2-amino-6-phenalkyl-aminopyridines and derivatives thereof
ES419319A1 (es) 1973-10-04 1976-03-01 Gallardo Antonio Sa Un procedimiento para la obtencion de derivados de acidos 3-benzoilfenilalcanoicos.
GB8909574D0 (en) * 1989-04-26 1989-06-14 Ici Plc Chemical process
US5169951A (en) * 1990-04-23 1992-12-08 Ciba-Geigy Corporation Process for preparing nematicidal compositions
DE69322118T2 (de) 1992-04-17 1999-05-20 Hodogaya Chemical Co Ltd Amino-Thiazolderivate und ihre Anwendung als Fungizide
US5556859A (en) * 1994-12-22 1996-09-17 Dowelanco N-(4-pyrimidinyl)amide pesticides
GB9823871D0 (en) 1998-10-30 1998-12-23 Pharmacia & Upjohn Spa 2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents
KR100455635B1 (ko) * 1999-03-29 2004-11-06 에프. 호프만-라 로슈 아게 글루코키나제 활성화제
JP4138478B2 (ja) * 2000-07-20 2008-08-27 エフ．ホフマン−ラ ロシュ アーゲー アルファ−アシル及びアルファ−ヘテロ原子置換ベンゼンアセトアミドのグルコキナーゼアクチベーター

Also Published As

Publication number Publication date
IL164780A (en) 2009-05-04
DE60309856T2 (de) 2007-06-14
EP1501815A1 (en) 2005-02-02
WO2003095438A9 (en) 2004-12-23
AU2003232204B8 (en) 2009-07-30
WO2003095438A1 (en) 2003-11-20
PA8572301A1 (es) 2004-05-26
TW200402418A (en) 2004-02-16
JP4091600B2 (ja) 2008-05-28
PE20040451A1 (es) 2004-07-21
NO20044534L (no) 2004-12-22
DK1501815T3 (da) 2007-04-02
US20060178429A1 (en) 2006-08-10
KR20040104633A (ko) 2004-12-10
EA011297B1 (ru) 2009-02-27
TWI281917B (en) 2007-06-01
MXPA04010605A (es) 2004-12-13
PT1501815E (pt) 2007-01-31
KR100669587B1 (ko) 2007-01-15
AU2003232204A1 (en) 2003-11-11
HRP20040953A2 (en) 2005-06-30
ATE346056T1 (de) 2006-12-15
JP2005535589A (ja) 2005-11-24
CN1649859A (zh) 2005-08-03
GT200300096A (es) 2004-01-15
CN1329386C (zh) 2007-08-01
NZ535706A (en) 2007-08-31
US20030225283A1 (en) 2003-12-04
US7259166B2 (en) 2007-08-21
UA80427C2 (en) 2007-09-25
HK1078088A1 (en) 2006-03-03
IL164780A0 (en) 2005-12-18
ES2276097T3 (es) 2007-06-16
TNSN04211A1 (fr) 2007-03-12
ZA200407986B (en) 2005-10-18
EP1501815B1 (en) 2006-11-22
UY27787A1 (es) 2003-10-31
MA27113A1 (fr) 2004-12-20
RS93604A (en) 2007-02-05
AU2003232204B2 (en) 2006-09-14
BR0309546A (pt) 2005-02-15
CA2482346A1 (en) 2003-11-20
DE60309856D1 (de) 2007-01-04
CA2482346C (en) 2010-03-09
ECSP045382A (es) 2005-01-03
AR039665A1 (es) 2005-03-02
US7105671B2 (en) 2006-09-12
PL373701A1 (en) 2005-09-05
MY135222A (en) 2008-02-29

Similar Documents

Publication Publication Date Title
EA200401398A1 (ru) Замещённые фенилацетамиды и их применение в качестве активаторов глюкокиназы
EA200300829A1 (ru) Производные 1-арил- или 1-алкилсульфонилбензазола в качестве лигандов 5-гидрокситриптамина-6
EA200400368A1 (ru) Новые дигидроптеридиноны, способы их получения и их применение в качестве лекарственных средств
EA200201046A1 (ru) 7- или 9-замещенные соединения тетрациклина, способ их получения (варианты), фармацевтическая композиция, способ лечения состояния, чувствительного к действию тетрациклина, у млекопитающего и реакционноспособное промежуточное производное
EA200801534A1 (ru) 3`-алкоксиспироциклопентилзамещенные тетрамовые и тетроновые кислоты
EA200500017A1 (ru) Новые соединения
EA200201119A1 (ru) Лиганды меланокортиновых рецепторов
AR091405A2 (es) Omega-carboxiaril difenil urea sustituida con fluoro y composiciones farmaceuticas que las contienen
EA199900853A1 (ru) Замещенные производные бензопирана для лечения воспалительных процессов
EA199800579A1 (ru) Новые производные 5-амино-3-циано-4-этилсульфинил-1-фенилпиразола и их применение в качестве пестицидов
EA200100315A1 (ru) Простые тетрагидропиридовые эфиры
EA199900936A1 (ru) Фунгицидные трифторметилалкиламинотриазолопиримидины
ATE368034T1 (de) Heteroarylsubstituierte biphenylderivate als inhibitoren von p38-kinase
EA199900598A1 (ru) Производные 1-арил- и пиридилпиразола с пестицидными свойствами
EA200401157A1 (ru) N-аминоацетилпирролидин-2-карбонитрилы и их применение в качестве ингибиторов ddp-iv
EA200400815A1 (ru) Контролируемый синтез зипразидона и его композиции
EA199900620A1 (ru) Фталазиноны
BRPI0415773A (pt) derivados de indolinona e sua aplicação no tratamento de estados de doença tais como cáncer
ATE290382T1 (de) Heterozyklische kalium-kanal inhibitoren
EA200500037A1 (ru) Фенилбензамиды
DK1562444T3 (da) Fremgangsmåde til formindskelse af acrylamidindholdet i varmebehandlede levnedsmidler
ATE412649T1 (de) Substituierte heteroarylbenzofuransäuren
EA200100012A1 (ru) Мостиковые инденопирролокарбазолы
CR8350A (es) 4-anilino-3-quinolincarbonitrilos para el tratamiento de leucemia mielogenica cronica
EA200201071A1 (ru) Циклопентилзамещенные производные глутарамида в качестве ингибиторов нейтральной эндопептидазы

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU